GetTopicDetailResponse(id=de5610194431, topicName=骨骼肌質(zhì)量, introduction=骨骼肌質(zhì)量, content=null, image=null, comments=0, allHits=1380, url=https://h5.medsci.cn/topic?id=101944, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=73821, tagList=[TagDto(tagId=73821, tagName=骨骼肌質(zhì)量)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2259904, encodeId=8cc42259904d1, content=<a href='/topic/show?id=1e47e697672' target=_blank style='color:#2F92EE;'>#索拉非尼#</a> <a href='/topic/show?id=b26f59861e3' target=_blank style='color:#2F92EE;'>#晚期肝癌#</a> <a href='/topic/show?id=de5610194431' target=_blank style='color:#2F92EE;'>#骨骼肌質(zhì)量#</a>, objectTitle=UEGJ：骨骼肌質(zhì)量可預(yù)測接受 SIRT 和索拉非尼治療的晚期肝癌患者的總生存期, objectType=article, longId=871301, objectId=6f868e1301f9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241227/1735286755162_8538692.png, objectUrl=/article/show_article.do?id=6f868e1301f9, replyNumber=0, likeNumber=30, createdTime=2025-04-10, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=6f868e1301f9, moduleTitle=UEGJ：骨骼肌質(zhì)量可預(yù)測接受 SIRT 和索拉非尼治療的晚期肝癌患者的總生存期, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6f868e1301f9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2201836, encodeId=8295220183671, content=<a href='/topic/show?id=c83253e4c4' target=_blank style='color:#2F92EE;'>#CT#</a> <a href='/topic/show?id=7dcd14265e4' target=_blank style='color:#2F92EE;'>#PICU#</a> <a href='/topic/show?id=de5610194431' target=_blank style='color:#2F92EE;'>#骨骼肌質(zhì)量#</a>, objectTitle=PCCM：PICU患者骨骼肌質(zhì)量評(píng)估方程的構(gòu)建及其相關(guān)因素, objectType=article, longId=824472, objectId=d3758244e2af, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230504/1683218649364_4754896.png, objectUrl=/article/show_article.do?id=d3758244e2af, replyNumber=0, likeNumber=0, createdTime=2024-05-05, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d3758244e2af, moduleTitle=PCCM：PICU患者骨骼肌質(zhì)量評(píng)估方程的構(gòu)建及其相關(guān)因素, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d3758244e2af)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2198127, encodeId=a3bc219812edd, content=<a href='/topic/show?id=ac125345160' target=_blank style='color:#2F92EE;'>#慢性丙型肝炎#</a> <a href='/topic/show?id=de5610194431' target=_blank style='color:#2F92EE;'>#骨骼肌質(zhì)量#</a>, objectTitle=APT：慢性丙型肝炎患者使用直接抗病毒藥物清除病毒后骨骼肌質(zhì)量增加, objectType=article, longId=821257, objectId=19a082125e67, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867593143_4754896.jpeg, objectUrl=/article/show_article.do?id=19a082125e67, replyNumber=0, likeNumber=125, createdTime=2024-04-12, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=19a082125e67, moduleTitle=APT：慢性丙型肝炎患者使用直接抗病毒藥物清除病毒后骨骼肌質(zhì)量增加, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=19a082125e67)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
